Episode
Episode 4: Smart drugs, dumb trials: rethinking the foundations of drug development
- Podcast
- Hypothesize That!
- Published
- Apr 29, 2026
- Duration seconds
- 1919
- Processing state
not_requested- Canonical source
- https://shows.acast.com/hypothesize-that/episodes/episode-4-smart-drugs-dumb-trials-rethinking-the-foundations
Actions
POST https://stenobird.com/v1/public/podcasts/hypothesize-that-7842584/episodes/episode-4-smart-drugs-dumb-trials-rethinking-the-foundations-of-drug-development/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/hypothesize-that-7842584/episode-4-smart-drugs-dumb-trials-rethinking-the-foundations-of-drug-development.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, host Nicola Hill, is joined by Professor Maddie Parsons, Dean of Research Excellence Frameworks at King’s College London, and Dr Graham Price, Head of Global Clinical Development at UCB, to examine whether today’s trials are fit for tomorrow’s science. Listen to our guests unpick the tensions in modern drug development from conservative endpoints, missed opportunities and lack of integration across clinical and scientific disciplines. Can smarter design, better data sharing, and deeper collaboration unlock the future of precision medicine? This podcast is produced and funded by UCB. Hosted on Acast. See acast.com/privacy for more information. GL-OT-2600003 – March 2026 Hosted on Acast. See acast.com/privacy for more information.